Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 06, 2021

SELL
$12.99 - $20.47 $6,910 - $10,890
-532 Closed
0 $0
Q2 2021

Jul 13, 2021

BUY
$15.46 - $24.5 $2,767 - $4,385
179 Added 50.71%
532 $12,000
Q1 2021

Apr 30, 2021

BUY
$19.33 - $37.75 $2,416 - $4,718
125 Added 54.82%
353 $9,000
Q4 2020

Jan 25, 2021

SELL
$24.48 - $42.47 $24 - $42
-1 Reduced 0.44%
228 $6,000
Q3 2020

Oct 29, 2020

BUY
$39.09 - $53.44 $8,482 - $11,596
217 Added 1808.33%
229 $8,000
Q3 2019

Nov 07, 2019

SELL
$58.69 - $80.46 $31,692 - $43,448
-540 Reduced 97.83%
12 $1,000
Q1 2019

May 15, 2019

SELL
$91.83 - $120.68 $92,656 - $121,766
-1,009 Reduced 64.64%
552 $62,000
Q4 2018

Jan 23, 2019

SELL
$85.79 - $126.46 $118,561 - $174,767
-1,382 Reduced 46.96%
1,561 $157,000
Q3 2018

Oct 25, 2018

SELL
$88.49 - $127.55 $48,757 - $70,280
-551 Reduced 15.77%
2,943 $0
Q2 2018

Aug 07, 2018

BUY
$60.0 - $85.67 $148,920 - $212,632
2,482 Added 245.26%
3,494 $0
Q1 2018

Jun 03, 2019

SELL
$52.72 - $67.25 $24,778 - $31,607
-470 Reduced 31.71%
1,012 $59,000
Q1 2018

May 09, 2018

BUY
$52.72 - $67.25 $24,778 - $31,607
470 Added 46.44%
1,482 $0
Q4 2017

Jan 24, 2018

SELL
$58.2 - $72.76 $85,554 - $106,957
-1,470 Reduced 59.23%
1,012 $0
Q3 2017

Oct 30, 2017

BUY
$57.01 - $118.75 $67,385 - $140,362
1,182 Added 90.92%
2,482 $144,000
Q2 2017

Jun 03, 2019

BUY
N/A
730 Added 128.07%
1,300 $157,000
Q2 2016

Jun 03, 2019

BUY
N/A
18 Added 3.26%
570 $81,000
Q1 2016

Jun 03, 2019

BUY
N/A
552
552 $62,000

Others Institutions Holding ICPT

About INTERCEPT PHARMACEUTICALS, INC.


  • Ticker ICPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,127,400
  • Description
  • Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...
More about ICPT
Track This Portfolio

Track Ifp Advisors, Inc Portfolio

Follow Ifp Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.